Position in PFE
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$3,424,537
-$422,479 QoQ
Shares Held
142,215
+3.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.71%
of 13F equity value
Holder Rank
#757
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NewSquare Capital LLC holds $30,198,865 across 9 Drug Manufacturers - General names. PFE ranks #5 (11.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
19,514 | $7,066,409 | |
| 2 | MRK |
Merck & Co., Inc.
|
51,991 | $6,680,843 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
43,664 | $5,516,509 | |
| 4 | SNY |
Sanofi
|
84,503 | $3,604,897 | |
| 5 | PFE |
Pfizer Inc
This page
|
142,215 | $3,424,537 | |
| 6 | GSK |
GSK plc
|
31,569 | $1,654,846 | |
| 7 | LLY |
ELI LILLY & Co
|
836 | $1,002,723 | |
| 8 | JNJ |
Johnson & Johnson
|
2,578 | $654,734 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,424,537 | 142,215 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $3,847,016 | 137,002 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $3,452,061 | 138,637 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,071,933 | 159,809 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,926,395 | 161,980 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $3,931,450 | 155,148 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $4,102,997 | 154,655 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $4,507,810 | 155,764 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $4,407,801 | 157,534 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $4,234,039 | 152,578 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $4,244,970 | 147,446 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $4,746,361 | 143,092 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $5,071,927 | 138,275 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $5,799,883 | 142,154 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $6,570,966 | 128,239 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $5,278,550 | 120,625 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $5,945,824 | 113,405 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $4,820,874 | 93,121 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $4,894,241 | 82,883 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $3,229,319 | 75,083 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,919,652 | 74,557 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $2,559,250 | 70,639 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $2,412,343 | 65,535 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $2,370,560 | 64,593 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $1,975,670 | 60,418 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $1,963,358 | 60,152 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||